Replimune Group Eulerpool Nieuws

Replimune Group Eulerpool News

Replimune Group Aandeel Nieuws

Replimune Group wordt door vele journalisten en beleggers wereldwijd gevolgd. De meest actuele Replimune Group nieuwsberichten verzamelen we hier.

• 18 september ·

  TipRanks
  Strong Phase 2 Results and Regulatory Progress Fuel Buy Rating for Replimune Group
• 16 september ·

  TipRanks
  Strong Buy Rating for Replimune Group on Robust Clinical and Regulatory Milestones
• 16 september ·

  TipRanks
  Barclays Releases a Buy Rating on Replimune Group (REPL)
• 15 september ·

  Yahoo
  Replimune Presents Primary Analysis Data from IGNYTE Clinical Trial of RP1 Combined with Nivolumab in Anti-PD1 Failed Melanoma at European Society for Medical Oncology (ESMO) Congress 2024
• 15 september ·

  Thefly.com
  Replimune presents primary analysis data from IGNYTE clinical trial
• 11 september ·

  SeekingAlpha
  Tracking Baker Brothers Portfolio - Q2 2024 Update
• 9 september ·

  Yahoo
  Replimune Announces Positive Pre-BLA Meeting with FDA and Confirms BLA Submission On Track for 2H 2024
• 5 september ·

  Yahoo
  Stockholders Vote to Elect Madhavan Balachandran to Board of Directors
• 5 september ·

  Thefly.com
  Replimune appoints Balachandran to board of directors
• 3 september ·

  SeekingAlpha
  Replimune: Strong Data In A Highly Differentiated Space